A detailed history of Nissay Asset Management Corp transactions in Viatris Inc stock. As of the latest transaction made, Nissay Asset Management Corp holds 140,761 shares of VTRS stock, worth $1.52 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
140,761
Previous 138,162 1.88%
Holding current value
$1.52 Million
Previous $1.5 Million 12.3%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $29,290 - $35,164
2,599 Added 1.88%
140,761 $1.68 Million
Q4 2023

Feb 14, 2024

BUY
$8.77 - $10.85 $54,470 - $67,389
6,211 Added 4.71%
138,162 $1.5 Million
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $39,971 - $47,306
4,168 Added 3.26%
131,951 $1.3 Million
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $29,874 - $34,080
-3,312 Reduced 2.53%
127,783 $1.28 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $42,632 - $56,812
-4,634 Reduced 3.41%
131,095 $1.26 Million
Q4 2022

Feb 14, 2023

SELL
$8.72 - $11.56 $48,884 - $64,805
-5,606 Reduced 3.97%
135,729 $1.51 Million
Q3 2022

Nov 14, 2022

BUY
$8.48 - $11.13 $42,679 - $56,017
5,033 Added 3.69%
141,335 $1.2 Million
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $6,547 - $8,073
-658 Reduced 0.48%
136,302 $1.43 Million
Q1 2022

May 16, 2022

BUY
$9.81 - $15.4 $30,008 - $47,108
3,059 Added 2.28%
136,960 $1.49 Million
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $66,083 - $80,240
5,466 Added 4.26%
133,901 $1.81 Million
Q3 2021

Nov 10, 2021

SELL
$13.25 - $15.13 $10,997 - $12,557
-830 Reduced 0.64%
128,435 $1.74 Million
Q2 2021

Aug 13, 2021

SELL
$12.97 - $16.15 $398,931 - $496,741
-30,758 Reduced 19.22%
129,265 $1.85 Million
Q1 2021

May 11, 2021

SELL
$13.59 - $18.54 $61,943 - $84,505
-4,558 Reduced 2.77%
160,023 $2.24 Million
Q4 2020

Feb 08, 2021

BUY
$14.3 - $18.74 $2.35 Million - $3.08 Million
164,581 New
164,581 $3.08 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.1B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Nissay Asset Management Corp Portfolio

Follow Nissay Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nissay Asset Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Nissay Asset Management Corp with notifications on news.